Faculty of Healthcare Administration (FHA)

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

Bacterial lysate medicines only for prevention of recurrent respiratory infections

28th June 2019

EMA has instructed that, from now onwards the bacterial lysate medicines should only be used against recurrent respiratory infections, with pneumonia as the only exception. This step was taken after reviewing that there is no robust data that can prove these medicines are effective in treating existing respiratory infection or prevention of pneumonia.

EMA’s human medicines committee (CHMP) used the clinical studies data, adverse event data related to these medicines and advice from the expert group.

The data was found to be limited but the review showed the effectiveness of these medicines in prevention of recurrent respiratory infections. Safety profile was also compliant. CHMP allowed the further use of these medicines but told the companies to provide more data on safety and effectiveness from new clinical studies by 2026.

Broken down bacterial cells are used to prepare Bacterial Lysate medicines. These medicines stimulate the immune system to recognize and fight infections. These medicines are available in the form of oral dosage form, as inhalation liquid through nasal cavity and in the form of intramuscular and subcutaneous injection.

For further enquiries, write to or call us on:
info@igmpiindia.org/ +91 8587838177, +91 8130924488, 0120-2427175, 0120-4375280

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Healthcare Newsletter

Featured Article

GMP: A continous process

Mr Vinod Arora, Principal Advisor, IGMPI

IGMPI Placement Blog

Placement Testimonials

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like